{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision

Activity Steps

Description

The certificate for this activity is for PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Understand the terminology of pathologic prognostic factors in rectal cancer
  2. Learn to risk stratify patients based on pathologic prognostic factors
  3. Evaluate the implication of prognostic pathologic features on potential adjuvant chemotherapy
Price: $10.00

Credits:

  • ACCME 1.5 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: DCR0723
Published: July 2023
Expires: 7/31/2026
Required Passing Score: 5/6 (83%)
Authors: Seijong Kim, M.D.& Jung Wook Huh, M.D., Ph.D.& Woo Yong Lee, M.D., Ph.D.& Seong Hyeon Yun, M.D., Ph.D.& Hee Cheol Kim, M.D., Ph.D. Yong Beom Cho, M.D., Ph.D. ; Yoon Ah Park, M.D. & Jung Kyong Shin, M.D.
Categories: Cancer , Surgical